Nongenomic actions of thyroid hormone

被引:189
作者
Davis, PJ [1 ]
Davis, FB [1 ]
机构
[1] STRATTON VET AFFAIRS MED CTR, ALBANY, NY 12208 USA
关键词
D O I
10.1089/thy.1996.6.497
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Nongenomic actions of thyroid hormone are by definition independent of nuclear receptors for the hormone and have been described at the plasma membrane, various cell organelles, the cytoskeleton, and in cytoplasm. The actions include alterations in solute transport (Ca2+, Na+, glucose), changes in activities of several kinases, including protein kinase C, cAMP-dependent protein kinase and pyruvate kinase M(2) (PKM(2)), effects on efficiency of specific mRNA translation and mRNA t(1/2), modulation of mitochondrial respiration, and regulation of actin polymerization (promotion of formation of F-actin). Iodothyronines also can regulate nongenomically the state of contractile elements in vascular smooth muscle cells (VSMC). The physiologic significance at the cellular level of certain of these actions has been demonstrated, for example, in the cases of myocardiocyte Na+ current, red cell Ca2+ content, and the control by hormone-induced alterations in actin solubility of cell surface activity of iodothyronine 5'-monodeiodinase activity and the intracellular distribution of protein disulfide isomerase activity. The physiologic significance of these actions at the organ or system level is less clear, but extranuclear effects of thyroid hormone on myocardial Na+ channel, sarcoplasmic reticulum Ca2+-ATPase activity, and contractile state of VSMC may each contribute to acute effects of thyroid hormone on cardiac output that have recently been described clinically. The molecular mechanisms for nongenomic actions are incompletely understood; relevant binding sites and signal transduction pathways have been described for hormone actions on plasma membrane Ca2+-ATPase activity, and PKM(2) monomer is known to bind T-3 and, as a result, prevent activation of the kinase via tetramer formation. Nongenomic actions of thyroid hormone may have different structure-activity relationships of iodothyronines from those effects that depend upon nuclear receptors; they may have different time courses and may invoke complex signal transduction pathways before the action is detected.
引用
收藏
页码:497 / 504
页数:8
相关论文
共 70 条
[1]   AN INVITRO NOVEL MECHANISM OF REGULATING THE ACTIVITY OF PYRUVATE KINASE-M2 BY THYROID-HORMONE AND FRUCTOSE-1,6-BISPHOSPHATE [J].
ASHIZAWA, K ;
MCPHIE, P ;
LIN, KH ;
CHENG, SY .
BIOCHEMISTRY, 1991, 30 (29) :7105-7111
[2]   INVITRO EFFECTS OF THYROXINE ON THE MECHANICAL-PROPERTIES OF ERYTHROCYTES [J].
BASKURT, OK ;
LEVI, E ;
TEMIZER, A ;
OZER, D ;
CAGLAYAN, S ;
DIKMENOGLU, N ;
ANDAC, SO .
LIFE SCIENCES, 1990, 46 (20) :1471-1477
[3]  
BRENT GA, 1994, NEW ENGL J MED, V331, P847
[4]   ROLE OF CALMODULIN IN THYROID-HORMONE STIMULATION INVITRO OF HUMAN-ERYTHROCYTE CA-2+-ATPASE ACTIVITY [J].
DAVIS, FB ;
DAVIS, PJ ;
BLAS, SD .
JOURNAL OF CLINICAL INVESTIGATION, 1983, 71 (03) :579-586
[5]   THYROID-HORMONE STIMULATION INVITRO OF RED-BLOOD-CELL CA2+-ATPASE ACTIVITY - INTERSPECIES VARIATION [J].
DAVIS, FB ;
KITE, JH ;
DAVIS, PJ ;
BLAS, SD .
ENDOCRINOLOGY, 1982, 110 (01) :297-298
[6]  
DAVIS FB, 1983, J BIOL CHEM, V258, P2373
[7]   INOSITOL PHOSPHATES MODULATE BINDING OF THYROID-HORMONE TO HUMAN RED-CELL MEMBRANES IN-VITRO [J].
DAVIS, FB ;
MOFFETT, MJ ;
DAVIS, PJ ;
ALOGAILY, MS ;
BLAS, SD .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 77 (05) :1427-1430
[8]   THYROID-HORMONE REGULATION OF MEMBRANE CA-2+-ATPASE ACTIVITY [J].
DAVIS, PJ ;
DAVIS, FB ;
LAWRENCE, WD .
ENDOCRINE RESEARCH, 1989, 15 (04) :651-682
[9]   INVITRO STIMULATION OF HUMAN RED-BLOOD-CELL CA2+-ATPASE BY THYROID-HORMONE [J].
DAVIS, PJ ;
BLAS, SD .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1981, 99 (04) :1073-1080
[10]  
DAVIS PJ, 1974, J BIOL CHEM, V249, P6208